EMV 2.91% $2.00 emvision medical devices ltd

Ann: Australian Stroke Alliance & FDA Update, page-213

  1. 1,027 Posts.
    lightbulb Created with Sketch. 634
    I'm was a little confused about the weights of the 'mobile' devices (EMV Gen 2 vs. MX1 ) here. But checking recent company presentations, it looks great for EMV:

    EMV's Gen 2 device has a targeted helmet weight of under 10kg (truly portable):

    https://hotcopper.com.au/data/attachments/5526/5526396-848bfff42c19cc26d512af1b49c740e5.jpg

    MX1's 'lightweight' CT scanner is 50kg (no one is taking this out in a backpack):
    https://hotcopper.com.au/data/attachments/5526/5526408-a895eefacb47fa202f3b3fd5ee6a440a.jpg

    As pointed out above, imaging and AI efficacy being equal, EMV is at a huge advantage. MX1's device will require road/air ambulance to be completely modified logistically in a place where space is already at a premium (look at the size of that thing. I believe paramedics talk about accounting for every bandage in an ambulance because of the space restrictions. EMV's device requires a place to put a backpack.




 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.